FDA Approves New Device That Targets Hard-To-Heal Ulcers

A new device hopes to heal ulcers that persist after six weeksIn my Houston podiatry practice, I always emphasize the importance of preventative foot care with my diabetic patients. After all, when it comes to your foot health, daily checks and bi-annual exams from your podiatrist can do a lot to keep wounds from progressing to the point where they are serious medical conditions.

Life, however, sometimes gets in the way of our best intentions. That fact is as true for me as it is for anyone else. Unfortunately, when diabetics neglect regular preventative foot health, even the smallest nick or tiniest blister can develop into an ulcer—a hard-to-heal wound that can ultimately result in the loss of your limb!

Ulcers are so dangerous because there is not any one treatment that can cure every wound. Each person’s feet are different, which means that you may have to go through many treatments before finding the one that works for you.

Given the challenge in treating ulcers, it’s always exciting when a new treatment option comes on the market—which has just happened. The Integra Omnigraft Dermal Regeneration Template—a device made up of silicone, cow collagen and shark cartilage that is designed to provide immediate wound closure and permanent skin regeneration—has just received FDA approval for treating wounds that have gone unhealed for longer than six weeks.

Again, I want to emphasize that not every individual will respond to available ulcer treatments, which is why ulcers are considered medical emergencies (and why it’s so important to do everything that we can to keep them from developing.) To learn more about how you can protect your feet from the effects of diabetes, schedule an appointment with Dr. Andrew Schneider.
Dr. Andrew Schneider
Connect with me
Dr. Andrew Schneider is a podiatrist and foot surgeon at Tanglewood Foot Specialists in Houston, TX.